Company Description

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders.

The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.

It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in New York.

Firefly Neuroscience, Inc.

Country	United States
Founded	2006
Industry	Software - Application
Sector	Technology
Employees	13
CEO	Greg Lipschitz

Contact Details

Address: 1100 Military Road, Kenmore, New York 14217 United States
Phone	888-237-6412
Website	fireflyneuro.com

Stock Details

Ticker Symbol	AIFF
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0000803578
CUSIP Number	317970101
ISIN Number	US3179701012
Employer ID	54-1167364
SIC Code	7372

Key Executives

Name	Position
Greg Lipschitz	Chief Executive Officer and Director
Paul Krzywicki CPA	Chief Financial Officer and Company Secretary
Gil Issachar	Chief Technology Officer
Dr. Jason DuBraski	Vice President of Sales

Latest SEC Filings

Date	Type	Title
Apr 17, 2025	SCHEDULE 13G/A	Filing
Apr 3, 2025	10-K	Annual Report
Apr 1, 2025	8-K	Current Report
Apr 1, 2025	NT 10-K	Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 12, 2025	8-K	Current Report
Feb 20, 2025	SCHEDULE 13G	Filing
Feb 14, 2025	8-K	Current Report
Feb 13, 2025	EFFECT	Notice of Effectiveness
Feb 11, 2025	UPLOAD	Filing
Feb 7, 2025	S-1	General form for registration of securities under the Securities Act of 1933

View All SEC Filings